Semaglutide is a medication that belongs to a class of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs). It is primarily used to treat type 2 diabetes and obesity management. Here are some key points about Semaglutide:

Type 2 Diabetes Treatment: Semaglutide is prescribed to individuals with type 2 diabetes to help lower blood sugar levels. It works by mimicking the effects of the natural hormone GLP-1, which stimulates the release of insulin and reduces the production of glucagon, thereby lowering blood glucose.

Administration: Semaglutide is injected once a week.  We inject it in the abs as a subcutaneous injection. This once weekly injection is convenient for many patients.

Benefits: Some of the benefits of Semaglutide include improved glycemic control, weight loss, and a lower risk of cardiovascular events in some patients. It can be used in combination with other diabetes medications.

Obesity Treatment: In addition to its use for diabetes, Semaglutide has been approved for the treatment of obesity. It slows down digestion and helps reduce appetite, leading to weight loss.

Side Effects: Common side effects of Semaglutide can include nausea, vomiting, diarrhea, and abdominal pain. These side effects often improve over time. Serious side effects are rare but can include pancreatitis and thyroid tumors.

Dosage: The weekly dosage of Semaglutide injections increases each month as long as patient is able to tolerate.  Dosage starts at 0.25mg weekly and increases to 0.5mg, 1mg, 1.7mg and 2.4mg,  The side effects are monitored by a healthcare provider to determine when the adjustments are made.

Precautions: Semaglutide may not be suitable for everyone. It's important to inform your healthcare provider of your medical history and any other medications you're taking. It should be used under the supervision and guidance of a qualified healthcare professional.

Semaglutide, like all medications, should be used as prescribed by a healthcare provider. It can be a valuable tool in the management of type 2 diabetes and obesity, but its use should be carefully monitored to ensure safety and effectiveness.

Step 1: Fill Out Application

Step 2: In Person Appointment

(No Telemedicine for Semaglutide)

Step 3: Register for Portal